Cleared Traditional

QardioArm 2 (K220106) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K220106 · Qardio, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2022
Decision
154d
Days
Class 2
Risk

K220106 is an FDA 510(k) clearance for the QardioArm 2. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Qardio, Inc. (San Fransciso, US). The FDA issued a Cleared decision on June 15, 2022 after a review of 154 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Qardio, Inc. devices

Submission Details

510(k) Number K220106 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 12, 2022
Decision Date June 15, 2022
Days to Decision 154 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
29d slower than avg
Panel avg: 125d · This submission: 154d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 285
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K220106.
Upper Arm Blood Pressure Monitor
K221212 · Shenzhen Yolanda Technology Co., Ltd. · Aug 2022
Upper Arm Type Blood Pressure Monitor
K220886 · Shenzhen Jamr Technology Co., Ltd. · Jul 2022
Wrist Type Blood Pressure Monitor
K220651 · Shenzhen Jamr Medical Technology Co., Ltd. · Jun 2022
Upper Arm Electronic Blood Pressure Monitor(Model FC-BP100,FC-BP101,FC-BP102,FC-BP110,FC-BP111,FC-BP112)
K220113 · Shenzhen Finicare Co., Ltd. · May 2022
LiveOne
K201302 · Livemetric (Medical) S.A. · May 2022
CareTaker Monitor App
K213699 · Caretaker Medical, LLC · Mar 2022